Continuous Erythropoietin Delivery by Muscle-Targeted Gene Transfer Usingin VivoElectroporation

Abstract

It has been demonstrated that gene transfer by in vivo electroporation of mouse muscle increases the level of gene expression by more than 100-fold over simple plasmid DNA injection. We tested continuous rat erythropoietin (Epo) delivery by this method in normal rats, using plasmid DNA expressing rat Epo (pCAGGSEpo) as the vector. A pair of electrodes was inserted into the thigh muscles of rat hind limbs and 100 mug of pCAGGS-Epo was injected between the electrodes. Eight 100-V, 50-msec electric pulses were delivered through the electrodes. Each rat was injected with a total of 400 mug of pCAGGS-Epo, which was delivered to the medial and lateral sides of each thigh. The presence of vector-derived Epo mRNA at the DNA injection site was confirmed by RT-PCR. The serum Epo levels peaked at 122.2 ± 33.0 mU/ml on day 7 and gradually decreased to 35.9 ± 18.2 mU/ml on day 32. The hematocrit levels increased continuously, from the preinjection level of 49.5 ± 1.1 to 67.8 ± 2.2% on day 32 (p<0.001). In pCAGGS-Epo treated rats, endogenous Epo secretion was downregulated on day 32. In a control experiment, intramuscular injection of pCAGGS-Epo without subsequent electroporation did not significantly enhance the serum Epo levels. These results demonstrate that muscle-targeted pCAGGS-Epo transfer by in vivo electroporation is a useful procedure for the continuous delivery of Epo.